2025
SJR Q2
JCR Q3 · 1,6
29 matched articles
SCIE
Journal detail
Alzheimer Disease and Associated Disorders
- Publisher
- Lippincott Williams and Wilkins
- Country
- United States · Northern America
- Type
- journal
- ISSN
-
0893034115464156
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 0,485
- Quartile Q2
- H-Index 116
- Cites/doc 1,54
- Docs (3y) 187
- Cites (3y) 289
Clarivate
Web of Science · JCR · 2025
- JCR Q Q3
- JIF 1,6
- 5Y JIF 1,8
- JCI 0,53
WoS indexes
- SCIE
Subject classification
Categories (SJR)
- Clinical Psychology Q2
- Geriatrics and Gerontology Q3
- Gerontology Q3
- Psychiatry and Mental Health Q3
Areas
- Medicine
- Nursing
- Psychology
WoS categories
- Clinical Neurology | Pathology
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q2 | Q3 | 0,485 | 1,6 | 1,8 | 0,53 | Q3 | 116 |
| 2024 | Q2 | Q3 | 0,685 | 1,4 | 2 | 0,6 | Q3 | 111 |
| 2023 | Q2 | Q3 | 0,609 | 1,8 | 2,5 | 0,62 | Q3 | 111 |
| 2022 | Q2 | Q3 | 0,676 | 2,1 | 3 | 0,68 | Q2 | 111 |
| 2021 | Q1 | Q3 | 0,88 | 2,4 | 3,6 | 0,76 | Q2 | 111 |
| 2020 | Q1 | Q3 | 1,213 | 2,7 | 3 | 0,8 | Q2 | 111 |
| 2019 | Q1 | Q2 | 1,152 | 2,1 | 2,7 | 0,91 | Q2 | 111 |
| 2018 | — | Q2 | — | 2,4 | 2,7 | 0,87 | Q2 | — |
| 2017 | Q1 | Q3 | 1,157 | 1,9 | 2,8 | 0,88 | Q2 | 111 |
| 2016 | Q1 | Q2 | 1,218 | 2,4 | 2,8 | — | — | 111 |
| 2015 | Q1 | Q2 | 1,393 | 2,5 | 3,1 | — | — | 111 |
| 2014 | Q1 | Q2 | 1,223 | 2,4 | 3,1 | — | — | 111 |
| 2013 | Q1 | Q2 | 1,089 | 2,7 | 2,9 | — | — | 111 |
| 2012 | Q1 | Q2 | 1,318 | 2,7 | 3,3 | — | — | 111 |
| 2011 | Q1 | Q2 | 1,356 | 2,8 | 3,3 | — | — | 111 |
| 2010 | Q1 | Q2 | 1,529 | 2,6 | 3,2 | — | — | 111 |
| 2009 | — | Q2 | — | 2,9 | 3,2 | — | — | — |
| 2008 | — | Q1 | — | 3,2 | 3,2 | — | — | — |
| 2007 | — | Q2 | — | 2,2 | 2,6 | — | — | — |
| 2006 | — | Q2 | — | 2 | — | — | — | — |
| 2005 | — | Q2 | — | 2 | — | — | — | — |
| 2004 | — | Q2 | — | 1,7 | — | — | — | — |
| 2003 | — | Q2 | — | 1,7 | — | — | — | — |
| 2002 | — | Q2 | — | 2 | — | — | — | — |
| 2001 | — | Q2 | — | 1,5 | — | — | — | — |
| 2000 | — | Q2 | — | 1,8 | — | — | — | — |
| 1999 | — | Q2 | — | 1,2 | — | — | — | — |
| 1998 | — | Q2 | — | 1 | — | — | — | — |
| 1997 | — | Q2 | — | 1,7 | — | — | — | — |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | CLINICAL NEUROLOGY | SCIE | Q4 | Q3 | 226/296 |
| 2025 | PATHOLOGY | SCIE | Q3 | Q3 | 57/89 |
| 2024 | CLINICAL NEUROLOGY | SCIE | Q4 | Q3 | 223/286 |
| 2024 | PATHOLOGY | SCIE | Q3 | Q3 | 58/90 |
| 2023 | CLINICAL NEUROLOGY | SCIE | Q3 | Q3 | 190/280 |
| 2023 | PATHOLOGY | SCIE | Q3 | Q3 | 50/88 |
| 2022 | CLINICAL NEUROLOGY | SCIE | Q4 | Q3 | 161/212 |
| 2022 | PATHOLOGY | SCIE | Q3 | Q2 | 46/76 |
| 2021 | CLINICAL NEUROLOGY | SCIE | Q4 | Q2 | 160/212 |
| 2021 | PATHOLOGY | SCIE | Q3 | Q2 | 48/77 |
| 2020 | CLINICAL NEUROLOGY | SCIE | Q3 | Q2 | 136/208 |
| 2020 | PATHOLOGY | SCIE | Q3 | Q2 | 40/77 |
| 2019 | CLINICAL NEUROLOGY | SCIE | Q3 | Q2 | 137/204 |
| 2019 | PATHOLOGY | SCIE | Q2 | Q2 | 38/78 |
| 2018 | CLINICAL NEUROLOGY | SCIE | Q3 | Q2 | 116/199 |
| 2018 | PATHOLOGY | SCIE | Q2 | Q2 | 30/76 |
| 2017 | CLINICAL NEUROLOGY | SCIE | Q3 | Q2 | 134/197 |
| 2017 | PATHOLOGY | SCIE | Q3 | Q2 | 42/79 |
| 2016 | CLINICAL NEUROLOGY | SCIE | Q3 | — | 99/194 |
| 2016 | PATHOLOGY | SCIE | Q2 | — | 27/79 |
| 2015 | CLINICAL NEUROLOGY | SCIE | Q2 | — | 86/193 |
| 2015 | PATHOLOGY | SCIE | Q2 | — | 26/79 |
| 2014 | CLINICAL NEUROLOGY | SCIE | Q2 | — | 84/192 |
| 2014 | PATHOLOGY | SCIE | Q2 | — | 28/76 |
| 2013 | CLINICAL NEUROLOGY | SCIE | Q2 | — | 77/194 |
| 2013 | PATHOLOGY | SCIE | Q2 | — | 22/76 |
| 2012 | CLINICAL NEUROLOGY | SCIE | Q2 | — | 71/193 |
| 2012 | PATHOLOGY | SCIE | Q2 | — | 22/77 |
| 2011 | CLINICAL NEUROLOGY | SCIE | Q2 | — | 67/192 |
| 2011 | PATHOLOGY | SCIE | Q2 | — | 21/79 |
| 2010 | CLINICAL NEUROLOGY | SCIE | Q2 | — | 74/185 |
| 2010 | PATHOLOGY | SCIE | Q2 | — | 23/76 |
| 2009 | CLINICAL NEUROLOGY | SCIE | Q2 | — | 53/167 |
| 2009 | PATHOLOGY | SCIE | Q2 | — | 20/71 |
| 2008 | CLINICAL NEUROLOGY | SCIE | Q1 | — | 37/156 |
| 2008 | PATHOLOGY | SCIE | Q2 | — | 18/69 |
| 2007 | CLINICAL NEUROLOGY | SCIE | Q2 | — | 64/146 |
| 2007 | PATHOLOGY | SCIE | Q2 | — | 24/66 |
| 2006 | CLINICAL NEUROLOGY | SCIE | Q2 | — | 70/147 |
| 2006 | PATHOLOGY | SCIE | Q2 | — | 28/64 |
| 2005 | CLINICAL NEUROLOGY | SCIE | Q2 | — | 60/148 |
| 2005 | PATHOLOGY | SCIE | Q2 | — | 26/66 |
| 2004 | CLINICAL NEUROLOGY | SCIE | Q2 | — | 60/140 |
| 2004 | PATHOLOGY | SCIE | Q2 | — | 23/65 |
| 2003 | CLINICAL NEUROLOGY | SCIE | Q2 | — | 62/135 |
| 2003 | PATHOLOGY | SCIE | Q2 | — | 28/64 |
| 2002 | CLINICAL NEUROLOGY | SCIE | Q2 | — | 49/138 |
| 2002 | PATHOLOGY | SCIE | Q2 | — | 20/64 |
| 2001 | CLINICAL NEUROLOGY | SCIE | Q2 | — | 49/136 |
| 2001 | PATHOLOGY | SCIE | Q2 | — | 23/66 |
| 2000 | CLINICAL NEUROLOGY | SCIE | Q2 | — | 46/137 |
| 2000 | PATHOLOGY | SCIE | Q2 | — | 17/67 |
| 1999 | CLINICAL NEUROLOGY | SCIE | Q3 | — | 68/132 |
| 1999 | PATHOLOGY | SCIE | Q2 | — | 29/66 |
| 1998 | CLINICAL NEUROLOGY | SCIE | Q3 | — | 68/125 |
| 1998 | PATHOLOGY | SCIE | Q2 | — | 31/68 |
| 1997 | CLINICAL NEUROLOGY | SCIE | Q2 | — | 33/107 |
| 1997 | PATHOLOGY | SCIE | Q2 | — | 20/66 |